REPLIGEN CORP - COMMON STOCK (RGEN)

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Equity / COMMON STOCK
Shares outstanding
56,095,854
Total 13F shares
40,224,387
Share change
+470,613
Total reported value
$2,376,319,121
Put/Call ratio
83%
Price per share
$59.08
Number of holders
241
Value change
+$32,032,553
Number of buys
130
Number of sells
109

Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q1 2019

As of 31 Mar 2019, REPLIGEN CORP - COMMON STOCK (RGEN) was held by 241 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 40,224,387 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, Invesco Ltd., STATE STREET CORP, FRED ALGER MANAGEMENT INC, Conestoga Capital Advisors, LLC, MACQUARIE GROUP LTD, OppenheimerFunds, Inc., and FEDERATED INVESTORS INC /PA/. This page lists 241 institutional shareholders reporting positions in this security for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.